abbvie stock buy or sell - Axtarish в Google
AbbVie stock has received a consensus rating of buy . The average rating score is and is based on 39 buy ratings, 3 hold ratings, and 1 sell ratings.
Оценка 4,0 (20) Is ABBV a Buy, Sell or Hold? AbbVie has a consensus rating of Moderate Buy which is based on 13 buy ratings, 7 hold ratings and 0 sell ratings. What is ...
170,35 $ Valuation metrics show that AbbVie Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and ...
Оценка 3,7 · StockInvest.us The AbbVie stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock.
Оценка 4,0 (14) In the last year, 14 stock analysts published opinions about ABBV-N. 10 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The ...
Оценка 4,6 (17) The consensus among 17 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. Out of 17 analysts, 13 (76.47%) are recommending ABBV as a ...
7 дней назад · Barring the recent fall, ABBV stock has fared well, with 90% gains since early January 2021 — jumping from levels of $92 then to around $175 now ...
8 нояб. 2024 г. · The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street ...
AbbVie currently has an average brokerage recommendation (ABR) of 1.63 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual ...
4 сент. 2024 г. · ABBV stock has gained 19.4% in the past three months compared with an increase of 8.1% for the industry. The stock has also outperformed the sector and S&P 500 ...
Novbeti >

 -  - 
Axtarisha Qayit
Anarim.Az


Anarim.Az

Sayt Rehberliyi ile Elaqe

Saytdan Istifade Qaydalari

Anarim.Az 2004-2023